Growth-hormone axis
Mod GRF 1-29
A modified fragment of growth hormone–releasing hormone, also called CJC-1295 without DAC.
- Type
- Peptide
- Research area
- Growth-hormone axis
- Research stage
- Laboratory and animal research
- FDA status
- Not an FDA-approved medicine
About Mod GRF 1-29
A modified fragment of growth hormone–releasing hormone, also called CJC-1295 without DAC.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
Related compounds
SermorelinSermorelin
A GHRH analog; the FDA-approved brand was discontinued and no approved version is marketed today.
CJC-1295CJC-1295
A growth hormone–releasing hormone analog studied in early clinical research.
IpamorelinIpamorelin
A growth-hormone secretagogue studied in clinical research.